Fake Avastin contained several chemicals, no drug

(AP) -- Counterfeit versions of the popular cancer drug Avastin obtained by European regulators contain a variety of chemicals, but not the active ingredient found in the genuine drug, according to drugmaker Roche.

The Swiss drugmaker says an analysis of the contents of the vials picked up traces of 10 substances, ranging from starch and salt to chemicals like acetone, a solvent used in paint thinner.

Roche said it is unclear whether the substances would cause harmful effects in patients.

The is investigating the source of counterfeit imported and distributed by a U.S. wholesaler to doctors here. Authorities in Europe have traced the counterfeit product back through distributors in Britain, Denmark and Switzerland. The original country of origin is still unclear.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Counterfeit toothpaste is discovered

Jun 14, 2007

The U.S. Food and Drug Administration said a counterfeit toothpaste falsely packaged as "Colgate" has been found in four states.

Counterfeit drugs becoming big business worldwide

Feb 16, 2012

(AP) -- The discovery that a fake version of the widely used cancer medicine Avastin is circulating in the United States is raising new fears that the multibillion-dollar drug-counterfeiting trade is increasingly ...

Recommended for you

Determine patient preferences by means of conjoint analysis

5 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

User comments